AR022620A1 - Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico - Google Patents

Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico

Info

Publication number
AR022620A1
AR022620A1 ARP000100674A ARP000100674A AR022620A1 AR 022620 A1 AR022620 A1 AR 022620A1 AR P000100674 A ARP000100674 A AR P000100674A AR P000100674 A ARP000100674 A AR P000100674A AR 022620 A1 AR022620 A1 AR 022620A1
Authority
AR
Argentina
Prior art keywords
treatment
neuropathic pain
aminoacil
pirroles
aroil
Prior art date
Application number
ARP000100674A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR022620A1 publication Critical patent/AR022620A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Los aroil aminoacil pirroles son farmacéuticamente utiles en el tratamiento de dolor neuropático, que incluye utilidad para el tratamiento de dolorneuropático.
ARP000100674A 1999-02-18 2000-02-17 Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico AR022620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12047799P 1999-02-18 1999-02-18

Publications (1)

Publication Number Publication Date
AR022620A1 true AR022620A1 (es) 2002-09-04

Family

ID=22390558

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100674A AR022620A1 (es) 1999-02-18 2000-02-17 Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico

Country Status (14)

Country Link
US (2) US6191142B1 (es)
EP (1) EP1154996B1 (es)
JP (1) JP2002537247A (es)
AR (1) AR022620A1 (es)
AT (1) ATE253556T1 (es)
AU (1) AU3367500A (es)
CA (1) CA2361390A1 (es)
DE (1) DE60006363T2 (es)
DK (1) DK1154996T3 (es)
ES (1) ES2209843T3 (es)
HK (1) HK1041003B (es)
TR (1) TR200103219T2 (es)
TW (1) TW562797B (es)
WO (1) WO2000048584A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573267B2 (en) 2000-06-30 2003-06-03 Ortho-Mcneil Pharmaceutical, Inc. Useful aroyl aminoacyl pyrrole compounds
ES2291373T3 (es) * 2000-12-20 2008-03-01 Ortho-Mcneil Pharmaceutical, Inc. Compuestos de isoquinolinil aroil pirrol para el tratamiento de trastornos del sistema nervioso central.
AU2002364545A1 (en) * 2001-12-27 2003-07-24 Ortho-Mcneil Pharmaceutical Inc. Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
WO2003066040A1 (fr) * 2002-02-05 2003-08-14 Ajinomoto Co.,Inc. Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n
HU230403B1 (hu) * 2003-12-19 2016-04-28 Pál Kocsis Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény
EP2256103A1 (en) 2009-05-07 2010-12-01 Biosynth AG Novel indicator platform

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332736A (en) * 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5418236A (en) * 1993-12-23 1995-05-23 Ortho Pharmaceutical Corporation Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles
EP0942752B1 (en) 1996-08-23 2005-04-20 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US5760007A (en) 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain

Also Published As

Publication number Publication date
WO2000048584A3 (en) 2000-12-07
AU3367500A (en) 2000-09-04
ATE253556T1 (de) 2003-11-15
US6369228B2 (en) 2002-04-09
EP1154996B1 (en) 2003-11-05
US6191142B1 (en) 2001-02-20
HK1041003B (zh) 2004-05-07
JP2002537247A (ja) 2002-11-05
TR200103219T2 (tr) 2002-04-22
WO2000048584A2 (en) 2000-08-24
ES2209843T3 (es) 2004-07-01
US20010044452A1 (en) 2001-11-22
DE60006363T2 (de) 2005-07-21
TW562797B (en) 2003-11-21
CA2361390A1 (en) 2000-08-24
DK1154996T3 (da) 2004-02-16
DE60006363D1 (de) 2003-12-11
HK1041003A1 (en) 2002-06-28
EP1154996A2 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
AR027059A1 (es) Bases de mannich indolicas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para la preparacion de medicamentos
ES2195970T3 (es) L-ribavirina y usos de la misma.
IT1285770B1 (it) Composti corticoidei
AR034699A1 (es) Procedimiento para la preparacion de moduladores del receptor glucocorticoide no esteroideos y compuestos intermediarios
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
AR022620A1 (es) Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico
AR031601A1 (es) Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
AR009809A1 (es) Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
PA8618401A1 (es) Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1.3,5(10)-trien-3,16alfa-diol
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
AR005704A1 (es) Heteroariloxazolidinonas
UY26498A1 (es) Pirroles sustituidos
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
AR009322A1 (es) Nuevas aril-piridazinas

Legal Events

Date Code Title Description
FB Suspension of granting procedure